In this Issue
The Why and The How
By Steven D. Vold, MD
By Alex S. Huang, MD, PhD, and Alan T. Begian
BENCH TO BEDSIDE
How laboratory glaucoma studies may help us better understand this clinical dilemma.
By Nathan Radcliffe, MD
By Katherine Fallano, MD, and Shakeel Shareef, MD
RESIDENTS AND FELLOWS
By Avni Shah, MD
Health care is of poorer quality and is harder to obtain in the countryside than in the cities.
By Nathan Congdon, MD, MPH
Innovation and Research in Clinical Practice
Participating in clinical research provides new options for my patients and growth opportunities for my practice.
By Gregory D. Parkhurst, MD
Three tips for getting started.
By Kevin LaMarche
Pearls from a private practitioner.
By Brian Flowers, MD
What you need to know.
By Julia M. Williams
Follow these steps to gain funding for your research endeavors.
By Lisa Hark, PhD, RD; Kamran Rahmatnejad, MD; Michael Waisbourd, MD; and L. Jay Katz, MD
It is a fact-based mission.
By Jacqueline Stader, COT, CCRC
This individual can make or break your research program.
By Vicki Williams
Protect your idea, create a prototype, and pinpoint the market opportunity.
By Timothy Buckley, MBA, BSME
The latest research findings from the 26th annual meeting of the American Glaucoma Society, held March 3 to 6, 2016, in Fort Lauderdale, Florida.
By Geoffrey T. Emerick, MD
Rho Kinase/Norepinephrine Transporter Inhibition for the Treatment of Glaucoma and Ocular Hypertension
An update on the clinical development of a new class of drugs.